Zomedica Corp. SEC filings ZOMDF
Zomedica Corp. has 482 filings in SEC EDGAR's recent list, going back to Sep 8, 2016. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-A12G | Form 8-a12g | Aug 20, 2025 | — |
| 25-NSE | Delisting notice | Mar 13, 2025 | — |
| UPLOAD | Letter from the SEC | Oct 16, 2024 | — |
| CORRESP | Letter to the SEC | Oct 9, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2024 | — |
| EFFECT | Filing | Oct 26, 2020 | — |
| 425 | Form 425 | Oct 26, 2020 | — |
| CORRESP | Letter to the SEC | Oct 22, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 14, 2020 | — |
| EFFECT | Filing | Jun 26, 2020 | — |
| CORRESP | Letter to the SEC | Jun 24, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2020 | — |
| EFFECT | Filing | May 26, 2020 | — |
| CORRESP | Letter to the SEC | May 20, 2020 | — |
| UPLOAD | Letter from the SEC | May 19, 2020 | — |
| D | Filing | Feb 14, 2020 | — |
| D | Filing | May 30, 2019 | — |
| EFFECT | Filing | Mar 18, 2019 | — |
| CT ORDER | Filing | Mar 18, 2019 | — |
| EFFECT | Filing | Jan 30, 2019 | — |
| DEL AM | Form del am | Jan 30, 2019 | — |
| CORRESP | Letter to the SEC | Jan 28, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 26, 2018 | — |
| CT ORDER | Filing | Aug 30, 2018 | — |
| D | Filing | May 18, 2018 | — |
| D | Filing | May 18, 2018 | — |
| EFFECT | Filing | Mar 30, 2018 | — |
| CT ORDER | Filing | Mar 7, 2018 | — |
| CT ORDER | Filing | Feb 5, 2018 | — |
| EFFECT | Filing | Nov 20, 2017 | — |
| CERTNYS | Auto-generated paper document | Nov 16, 2017 | — |
| CORRESP | Letter to the SEC | Nov 16, 2017 | — |
| 8-A12B | Form 8-a12b | Nov 15, 2017 | — |
| D | Filing | Aug 2, 2017 | — |
| CORRESP | Letter to the SEC | May 24, 2017 | — |
| CORRESP | Letter to the SEC | May 22, 2017 | — |
| UPLOAD | Letter from the SEC | May 5, 2017 | — |
| CORRESP | Letter to the SEC | Apr 21, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 28, 2017 | — |
| DRSLTR | Filing | Mar 9, 2017 | — |
| DRS/A | Filing | Mar 9, 2017 | — |
| UPLOAD | Letter from the SEC | Jan 10, 2017 | — |
| D | Filing | Jan 4, 2017 | — |
| D | Filing | Jan 4, 2017 | — |
| DRS | Filing | Dec 13, 2016 | — |
| D | Filing | Sep 8, 2016 | — |
Showing 46 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ZOMDF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Alberta, Canada
- Headquarters
- Ann Arbor, MI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1684144
- Former names
- Zomedica Pharmaceuticals Corp. (until Sep 28, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.